Dana-Farber Cancer Institute Chooses MicroStrategy for Clinical Operations and Clinical Research Reporting Applications
MicroStrategy® Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Dana-Farber Cancer Institute has selected the MicroStrategy Business Intelligence Platform� for clinical operations and clinical research reporting applications
McLean, Va., (January 21, 2009) –
MicroStrategy® Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Dana-Farber Cancer Institute has selected the MicroStrategy Business Intelligence Platform(TM) for clinical operations and clinical research reporting applications. Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States.
Dana-Farber will use MicroStrategy for its clinical operations reporting application, which will be used by clinic managers, nurses, disease program administrators, and schedulers to improve their ability to manage patient flow through clinical areas, reduce wait times, optimize clinical processes like pharmacy dispenses and medical records management, and monitor staffing levels. Clinical research assistants, statisticians, doctors, and clinical researchers will use the MicroStrategy-based clinical research reporting application for insights into data that will help them write research papers and grants, identify patients for clinical studies, and better understand treatment outcomes.
“We selected MicroStrategy because we needed a fully integrated business intelligence platform that was reliable, scalable, and easy to use,” said John Orechia, Clinical and Research Reporting Team Leader of Dana-Farber Cancer Institute. “With MicroStrategy’s robust reporting and intuitive Web interface, our personnel will have access to the information they need to make essential decisions for our organization and our patients.”
“We are proud to support Dana-Farber Cancer Institute and its multiple reporting applications,” said MicroStrategy’s COO Sanju Bansal. “Organizations across the healthcare industry rely on MicroStrategy to analyze and improve operations, service quality, and resource utilization.”
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute.
About MicroStrategy
Founded in 1989, MicroStrategy is a global leader in business intelligence (BI) technology. MicroStrategy provides integrated reporting, analysis, and monitoring software that helps leading organizations worldwide make better business decisions every day. Companies choose MicroStrategy for its advanced technical capabilities, sophisticated analytics, and superior data and user scalability. More information about MicroStrategy (Nasdaq: MSTR) is available at www.microstrategy.com.
MicroStrategy, MicroStrategy Business Intelligence Platform are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.
Wende Cover
MicroStrategy, Incorporated
1-703-770-1646
wcover@microstrategy.com
Source: MicroStrategy